Appiah-Kusi E, Leyden E, Parmar S, Mondelli V, McGuire P, Bhattacharyya S (2016) Abnormalities in neuroendocrine stress response in psychosis: the role of endocannabinoids. Psychol Med 46:27–45
Article
CAS
PubMed
Google Scholar
Beards S, Gayer-Anderson C, Borges S, Dewey ME, Fisher HL, Morgan C (2013) Life events and psychosis: a review and meta-analysis. Schizophr Bull 39:740–747
Article
PubMed
PubMed Central
Google Scholar
Bebbington P, Nayani T (1995) The psychosis screening questionnaire. Methods in Psychiatric Research, International Journal of
Google Scholar
Bergamaschi MM, Queiroz RHC, Chagas MHN, De Oliveira DCG, De Martinis BS, Kapczinski F, Quevedo J, Roesler R, Schröder N, Nardi AE (2011b) Cannabidiol reduces the anxiety induced by simulated public speaking in treatment-naive social phobia patients. Neuropsychopharmacology 36:1219–1226
Article
CAS
PubMed
PubMed Central
Google Scholar
Bergamaschi M, Mateus, Queiroz RHC, Zuardi AW, Crippa AS (2011a) Safety and side effects of cannabidiol, a Cannabis sativa constituent. Curr Drug Saf 6:237–249
Article
CAS
PubMed
Google Scholar
Bhattacharyya S, Morrison PD, Fusar-Poli P, Martin-Santos R, Borgwardt S, Winton-Brown T, Nosarti C, MO’Carroll C, Seal M, Allen P (2010) Opposite effects of Δ-9-tetrahydrocannabinol and cannabidiol on human brain function and psychopathology. Neuropsychopharmacology 35:764
Article
CAS
PubMed
Google Scholar
Bhattacharyya S, Crippa JA, Allen P, Martin-Santos R, Borgwardt S, Fusar-Poli P, Rubia K, Kambeitz J, O’carroll C, Seal ML (2012) Induction of psychosis byδ9-tetrahydrocannabinol reflects modulation of prefrontal and striatal function during attentional salience processing. Arch Gen Psychiatry 69:27–36
Article
CAS
PubMed
Google Scholar
Bhattacharyya S, Falkenberg I, Martin-Santos R, Atakan Z, Crippa JA, Giampietro V, Brammer M, McGuire P (2015) Cannabinoid modulation of functional connectivity within regions processing attentional salience. Neuropsychopharmacology 40:1343
Article
CAS
PubMed
PubMed Central
Google Scholar
Bhattacharyya S, Wilson R, Appiah-Kusi E, O’Neill A, Brammer M, Perez J, Murray R, Allen P, Bossong MG, McGuire P (2018) Effect of cannabidiol on medial temporal, midbrain, and striatal dysfunction in people at clinical high risk of psychosis: a randomized clinical trial. JAMA Psychiatry 75:1107–1117
Article
PubMed
PubMed Central
Google Scholar
Bih CI, Chen T, Nunn AVW, Bazelot M, Dallas M, Whalley BJ (2015) Molecular targets of cannabidiol in neurological disorders. Neurotherapeutics 12:699–730
Article
CAS
Google Scholar
Bose M, Oliván B, Laferrère B (2009) Stress and obesity: the role of the hypothalamic–pituitary–adrenal axis in metabolic disease. Current opinion in endocrinology, diabetes, and obesity 16:340
Article
CAS
PubMed
PubMed Central
Google Scholar
Campos AC, Guimarães FS (2008) Involvement of 5HT1A receptors in the anxiolytic-like effects of cannabidiol injected into the dorsolateral periaqueductal gray of rats. Psychopharmacology 199:223
Article
CAS
PubMed
Google Scholar
Campos AC, de Paula Soares V, Carvalho MC, Ferreira FR, Vicente MA, Brandão ML, Zuardi AW, Zangrossi H, Guimarães FS (2013) Involvement of serotonin-mediated neurotransmission in the dorsal periaqueductal gray matter on cannabidiol chronic effects in panic-like responses in rats. Psychopharmacology 226:13–24
Article
CAS
PubMed
Google Scholar
Cohrs S, Röher C, Jordan W, Meier A, Huether G, Wuttke W, Rüther E, Rodenbeck A (2006) The atypical antipsychotics olanzapine and quetiapine, but not haloperidol, reduce ACTH and cortisol secretion in healthy subjects. Psychopharmacology 185:11–18
Article
CAS
PubMed
Google Scholar
Collip D, Nicolson NA, Lardinois M, Lataster T, Van Os J, Myin-Germeys I (2011) Daily cortisol, stress reactivity and psychotic experiences in individuals at above average genetic risk for psychosis. Psychol Med 41:2305–2315
Article
CAS
PubMed
Google Scholar
D’Souza DC, Abi-Saab WM, Madonick S, Forselius-Bielen K, Doersch A, Braley G, Gueorguieva R, Cooper TB, Krystal JH (2005) Delta-9-tetrahydrocannabinol effects in schizophrenia: implications for cognition, psychosis, and addiction. Biol Psychiatry 57:594–608
Article
CAS
PubMed
Google Scholar
Day FL, Valmaggia LR, Mondelli V, Papadopoulos A, Papadopoulos I, Pariante CM, McGuire P (2014) Blunted cortisol awakening response in people at ultra high risk of developing psychosis. Schizophr Res 158:25–31
Article
PubMed
Google Scholar
Engert V, Efanov SI, Duchesne A, Vogel S, Corbo V, Pruessner JC (2013) Differentiating anticipatory from reactive cortisol responses to psychosocial stress. Psychoneuroendocrinology 38:1328–1337
Article
CAS
PubMed
Google Scholar
Fink, George. 2000. Encyclopedia of stress (academic press)
Google Scholar
Fogaça, Manoela V, Alline C Campos, and Francisco S Guimarães. 2016. 'Cannabidiol and 5-HT 1A receptors.' in, Neuropathology of Drug Addictions and Substance Misuse (Elsevier)
Fogaça MV, Campos AC, Coelho LD, Duman RS, Guimarães FS (2018) The anxiolytic effects of cannabidiol in chronically stressed mice are mediated by the endocannabinoid system: role of neurogenesis and dendritic remodeling. Neuropharmacology 135:22–33
Article
CAS
PubMed
Google Scholar
Gomes FV, Resstel LBM, Guimarães FS (2011) The anxiolytic-like effects of cannabidiol injected into the bed nucleus of the stria terminalis are mediated by 5-HT1A receptors. Psychopharmacology 213:465–473
Article
CAS
PubMed
Google Scholar
Gomes FV, Reis DG, Alves FHF, Corrêa FMA, Guimaraes FS, Resstel LBM (2012) Cannabidiol injected into the bed nucleus of the stria terminalis reduces the expression of contextual fear conditioning via 5-HT1A receptors. J Psychopharmacol 26:104–113
Article
CAS
PubMed
Google Scholar
Guimarães FS, Chiaretti TM, Graeff FG, Zuardi AW (1990) Antianxiety effect of cannabidiol in the elevated plus-maze. Psychopharmacology 100:558–559
Article
PubMed
Google Scholar
Hofmann SG, DiBartolo PM (2000) An instrument to assess self-statements during public speaking: scale development and preliminary psychometric properties. Behav Ther 31:499–515
Article
CAS
PubMed
PubMed Central
Google Scholar
Iseger TA, Bossong MG (2015) A systematic review of the antipsychotic properties of cannabidiol in humans. Schizophr Res 162:153–161
Article
PubMed
Google Scholar
Jansen LMC, Gispen-de Wied CC, Gademan PJ, De Jonge RCJ, van der Linden JA, Kahn RS (1998) Blunted cortisol response to a psychosocial stressor in schizophrenia. Schizophr Res 33:87–94
Article
CAS
PubMed
Google Scholar
Jansen LMC, Gispen-de Wied CC, Kahn RS (2000) Selective impairments in the stress response in schizophrenic patients. Psychopharmacology 149:319–325
Article
CAS
PubMed
Google Scholar
Kirschbaum C, Pirke K-M, Hellhammer DH (1993) The ‘Trier Social Stress Test’–a tool for investigating psychobiological stress responses in a laboratory setting. Neuropsychobiology 28:76–81
Article
CAS
PubMed
Google Scholar
Kirschbaum C, Kudielka BM, Gaab J, Schommer NC, Hellhammer DH (1999) Impact of gender, menstrual cycle phase, and oral contraceptives on the activity of the hypothalamus-pituitary-adrenal axis. Psychosom Med 61:154–162
Article
CAS
PubMed
Google Scholar
Kudielka BM, Buchtal J, Uhde A, Wüst S (2007b) Circadian cortisol profiles and psychological self-reports in shift workers with and without recent change in the shift rotation system. Biol Psychol 74:92–103
Article
PubMed
Google Scholar
Kudielka BM, Hellhammer DH, Kirschbaum C, Harmon-Jones E, Winkielman P (2007a) Ten years of research with the Trier social stress test—revisited. Social neuroscience: Integrating biological and psychological explanations of social behavior:56–83
Leweke FM, Piomelli D, Pahlisch F, Muhl D, Gerth CW, Hoyer C, Klosterkötter J, Hellmich M, Koethe D (2012) Cannabidiol enhances anandamide signaling and alleviates psychotic symptoms of schizophrenia. Transl Psychiatry 2:e94
Article
CAS
PubMed
PubMed Central
Google Scholar
McGuire, Philip, Philip Robson, Wieslaw Jerzy Cubala, Daniel Vasile, Paul Dugald Morrison, Rachel Barron, Adam Taylor, and Stephen Wright. 2017. 'Cannabidiol (CBD) as an adjunctive therapy in schizophrenia: a multicenter randomized controlled trial', American Journal of Psychiatry: appi. ajp. 2017.17030325
Mondelli V, Dazzan P, Hepgul N, Di Forti M, Aas M, D’Albenzio A, Di Nicola M, Fisher H, Handley R, Marques TR, Morgan C, Navari S, Taylor H, Papadopoulos A, Aitchison KJ, Murray RM, Pariante CM (2010) Abnormal cortisol levels during the day and cortisol awakening response in first-episode psychosis: the role of stress and of antipsychotic treatment. Schizophr Res 116:234–242
Article
PubMed
Google Scholar
Pruessner JC, Kirschbaum C, Meinlschmid G, Hellhammer DH (2003) Two formulas for computation of the area under the curve represent measures of total hormone concentration versus time-dependent change. Psychoneuroendocrinology 28:916–931
Article
CAS
PubMed
Google Scholar
Pruessner M, Béchard-Evans L, Boekestyn L, Iyer SN, Pruessner JC, Malla AK (2013) Attenuated cortisol response to acute psychosocial stress in individuals at ultra-high risk for psychosis. Schizophr Res 146:79–86
Article
PubMed
Google Scholar
Pruessner M, Cullen AE, Aas M, Walker EF (2017) The neural diathesis-stress model of schizophrenia revisited: an update on recent findings considering illness stage and neurobiological and methodological complexities. Neurosci Biobehav Rev 73:191–218
Article
PubMed
Google Scholar
Russo EB, Burnett A, Hall B, Parker KK (2005) Agonistic properties of cannabidiol at 5-HT1a receptors. Neurochem Res 30:1037–1043
Article
CAS
PubMed
Google Scholar
Spielberger, Charles Donald, Richard L Gorsuch, and Robert E Lushene. 1970. ‘Manual for the state-trait anxiety inventory’
van Venrooij JAEM, Fluitman SBAHA, Lijmer JG, Kavelaars A, Heijnen CJ, Westenberg HGM, Kahn RS, Gispen-de Wied CC (2012) Impaired neuroendocrine and immune response to acute stress in medication-naive patients with a first episode of psychosis. Schizophr Bull 38:272–279
Article
PubMed
Google Scholar
van Winkel R, Stefanis NC, Myin-Germeys I (2008) Psychosocial stress and psychosis. A review of the neurobiological mechanisms and the evidence for gene-stress interaction. Schizophr Bull 34:1095–1105
Article
PubMed
PubMed Central
Google Scholar
Walter EE, Fernandez F, Snelling M, Barkus E (2018) Stress induced cortisol release and schizotypy. Psychoneuroendocrinology 89:209–215
Article
CAS
PubMed
Google Scholar
Yung, Alison R, Lisa J Phillips, Patrick D McGorry, Colleen A McFarlane, Shona Francey, Susan Harrigan, George C Patton, and Henry J Jackson. 1998. 'Prediction of psychosis: a step towards indicated prevention of schizophrenia', The British Journal of Psychiatry
Yung AR, Yung AR, Yuen HP, Mcgorry PD, Phillips LJ, Kelly D, Dell’olio M, Francey SM, Cosgrave EM, Killackey E (2005) Mapping the onset of psychosis: the comprehensive assessment of at-risk mental states. Australian & New Zealand Journal of Psychiatry 39:964–971
Article
Google Scholar
Zhang XY, Zhou DF, Cao LY, Wu GY, Shen YC (2005) Cortisol and cytokines in chronic and treatment-resistant patients with schizophrenia: association with psychopathology and response to antipsychotics. Neuropsychopharmacology 30:1532
Article
CAS
PubMed
Google Scholar
Zuardi AW, Shirakawa I, Finkelfarb E, Karniol IG (1982) Action of cannabidiol on the anxiety and other effects produced by Δ 9-THC in normal subjects. Psychopharmacology 76:245–250
Article
CAS
PubMed
Google Scholar
Zuardi AW, Cosme RA, Graeff FG, Guimarães FS (1993) Effects of ipsapirone and cannabidiol on human experimental anxiety. J Psychopharmacol 7:82–88
Article
CAS
PubMed
Google Scholar
Zuardi, Antonio W, Natália P Rodrigues, Angélica L Silva, Sandra A Bernardo, Jaime EC Hallak, Francisco S Guimarães, and José AS Crippa. 2017. ‘Inverted U-shaped dose-response curve of the anxiolytic effect of cannabidiol during public speaking in real life’, Frontiers in pharmacology, 8